Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure

被引：0
|
作者：
Gustav Mattsson
Marita Wallhagen
Peter Magnusson
机构：
[1] Uppsala University/Region Gävleborg,Centre for Research and Development
[2] University of Gävle,Department of Building Engineering, Energy Systems and Sustainability Science
[3] Karolinska Institutet,Cardiology Research Unit, Department of Medicine
来源：
BMC Cardiovascular Disorders | / 21卷
关键词：
Cardiomyopathy; Heart failure; Implantable cardioverter defibrillator; Kansas City Cardiomyopathy Questionnaire; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure
    Mattsson, Gustav
    Wallhagen, Marita
    Magnusson, Peter
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [2] Validation of the Portuguese Version of the Kansas City Cardiomyopathy Questionnaire-12
    dos Reis, Mariane Cecilia
    Nascimento, Juliana Araujo
    de Andrade, Geisa Nascimento
    Costa, Ana Claudia de Souza
    Takada, Julio Yoshio
    Mansur, Antonio de Padua
    Bocchi, Edimar Alcides
    dos Santos, Gianni Mara Silva
    Spertus, John A.
    Nakagawa, Naomi Kondo
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (04)
  • [3] Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction
    Yang, Mingming
    Kondo, Toru
    Adamson, Carly
    Butt, Jawad H.
    Abraham, William T.
    Desai, Akshay S.
    Jering, Karola S.
    Kober, Lars
    Kosiborod, Mikhail N.
    Packer, Milton
    Rouleau, Jean L.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    Zile, Michael R.
    Jhund, Pardeep S.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1606 - 1618
  • [4] The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Sauer, Andrew J.
    Sherrod, Charles F.
    Gosch, Kensey L.
    Arnold, Suzanne V.
    Reaney, Matthew
    Zhong, Yue
    Lam, Jenny
    Wyrwich, Kathleen W.
    Spertus, John A.
    CIRCULATION, 2023, 148
  • [5] The follow-up of patients with chronic heart failure and implantable cardioverter defibrillator in primary prevention
    Kerekanic, Michal
    Misikova, S.
    Komanova, E.
    Sedlak, J.
    Farkas, J.
    Stancak, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 38 - 39
  • [6] IS THERE A GENDER DISPARITY IN PATIENTS WITH SYSTOLIC HEART FAILURE RECEIVING AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FOR PRIMARY PREVENTION?
    Nahass, Meghan
    Hiltner, Emily
    Srivastava, Shreya
    Kassotis, John
    Sethi, Ankur
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 181 - 181
  • [7] The implantable cardioverter defibrillator in congestive heart failure patients in primary prevention: assessment of neuropsychological impact
    Garnero, S.
    Pomero, A.
    Vallauri, P.
    Leto, L.
    Testa, M.
    Feola, M.
    MINERVA CARDIOANGIOLOGICA, 2014, 62 (04): : 321 - 326
  • [8] Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure
    Green, CP
    Porter, CB
    Bresnahan, DR
    Spertus, JA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (05) : 1245 - 1255
  • [9] Primary prevention implantable cardioverter defibrillators for patients with heart failure
    Beggs, Simon A. S.
    Wright, Gary A.
    Gardner, Roy S.
    HEART, 2024, 110 (01) : 65 - 73
  • [10] Syncope in Primary Prevention Implantable Cardioverter Defibrillator Patients
    Goldenberg, Gustavo
    Bental, Tamir
    Kadmon, Udi
    Zabarsky, Ronit
    Kusnick, Jairo
    Barsheshet, Mon
    Golovchiner, Gregory
    Strasberg, Boris
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (06): : 318 - 321
12345